We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Psychemedics Corp (PMD) Common Stock USD0.005

Sell:$2.53 Buy:$3.15 Change: $0.01 (0.39%)
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
Sell:$2.53
Buy:$3.15
Change: $0.01 (0.39%)
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
Sell:$2.53
Buy:$3.15
Change: $0.01 (0.39%)
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.

Contact details

Address:
125 Nagog Park Ste 200
ACTON
01720-3451
United States
Telephone:
+1 (978) 2068220
Website:
https://www.psychemedics.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PMD
ISIN:
US7443752057
Market cap:
$15.36 million
Shares in issue:
5.81 million
Sector:
Health Care Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Brian Hullinger
    President, Chief Executive Officer, Director
  • Daniella Mehalik
    Vice President - Finance, Treasurer
  • Shannon Shoemaker
    Chief Revenue Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.